Table Of Contents:
- Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
- Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
- Chapter 3. Acute Kidney Injury (AKI) Market: By Treatment Type Market Trends, Size, and Future Outlook
- Treatment Type Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Treatment Type Definitions, Technology Landscape
- Treatment Type Market Drivers
- Product Launches
- Technology Launches
- Treatment Type Market Restraints
- Chapter 4. Acute Kidney Injury (AKI) Market: By Drug Type Market Trends, Size, and Future Outlook
- Drug Type Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Drug Type Definitions, Technology Landscape
- Drug Type Market Drivers
- Product Launches
- Technology Launches
- Drug Type Market Restraints
- Chapter 5. Acute Kidney Injury (AKI) Market: By Route of Administration Market Trends, Size, and Future Outlook
- Route of Administration Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Route of Administration Definitions, Technology Landscape
- Route of Administration Market Drivers
- Product Launches
- Technology Launches
- Route of Administration Market Restraints
- Chapter 6. Acute Kidney Injury (AKI) Market: By End-User Market Trends, Size, and Future Outlook
- End-User Market Size (US$), CAGR (%), and Forecast (2023-2031)
- End-User Definitions, Technology Landscape
- End-User Market Drivers
- Product Launches
- Technology Launches
- End-User Market Restraints
- Chapter 7. Acute Kidney Injury (AKI) Market: By Cause Market Trends, Size, and Future Outlook
- Cause Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Cause Definitions, Technology Landscape
- Cause Market Drivers
- Product Launches
- Technology Launches
- Cause Market Restraints
- Chapter 8. Acute Kidney Injury (AKI) Market: By Stage Market Trends, Size, and Future Outlook
- Stage Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Stage Definitions, Technology Landscape
- Stage Market Drivers
- Product Launches
- Technology Launches
- Stage Market Restraints
- Chapter 9. Acute Kidney Injury (AKI) Market: By Severity Market Trends, Size, and Future Outlook
- Severity Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Severity Definitions, Technology Landscape
- Severity Market Drivers
- Product Launches
- Technology Launches
- Severity Market Restraints
- Chapter 10. Acute Kidney Injury (AKI) Market: Regional Market Trends, Size, and Future Outlook
- North America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Europe
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Asia Pacific
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Latin America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Middle East, and Africa
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- North America
- Acute Kidney Injury (AKI) Market: Competitive Landscape
- Baxter International Inc.
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- Angion Biomedica Corp.
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- Quipu Life
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- AM-Pharma
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- Asahi Kasei Medical Co., Ltd.
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- Novartis AG
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- Pfizer Inc.
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- Sanofi
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- GlaxoSmithKline plc
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- AstraZeneca
-
-
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
-
-
- Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
- Appendix
- About Us
Frequently Asked Questions
The current market size of the Acute Kidney Injury (AKI) industry is US$ 920 million.
The key factors contributing significantly to the growth of the Acute Kidney Injury (AKI) market include the rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases, increasing healthcare expenditure, advancements in diagnostic techniques, and technological advancements in treatment modalities.
The key factors hampering the growth of the Acute Kidney Injury (AKI) Market include the high cost of treatment, stringent regulatory requirements, lack of awareness and early detection, and limited treatment options.
The leading component segment in the Acute Kidney Injury (AKI) Market is the Drugs segment, which includes various therapeutic agents used for the treatment of AKI.
The major players operating in the Acute Kidney Injury (AKI) Market include Baxter International Inc., Angion Biomedica Corp., Quipu Life, AM-Pharma, Asahi Kasei Medical Co., Ltd., Novartis AG, Pfizer Inc., Sanofi, GlaxoSmithKline plc, and AstraZeneca.
The Acute Kidney Injury (AKI) Market is expected to reach US$ 1,929.5 billion by 2031, growing at a CAGR of 9.7% during the forecast period.
The key drivers of the Acute Kidney Injury (AKI) Market include the rising prevalence of chronic diseases, increasing healthcare expenditure, advancements in diagnostic techniques, and technological advancements in treatment modalities.